On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This significant trade comes in the wake of Wood's previous remarks about the tech giant being "really expensive and very obvious".
The NVIDIA Trade
Ark sold 8983 shares of the Jensen Huang-led company through the ARK Genomic Revolution ETF (BATS:ARKG). The transaction was valued at $4.02 million — based on the stock's closing price of $447.82 on Monday.
Ark Invest's decision to offload NVIDIA shares aligns with Cathie Wood's earlier sentiments. Wood has been vocal about her perspective, considering other less obvious but profitable avenues in the AI sector. The sale of NVIDIA, a company that recently crossed $1 trillion in market cap due to its 191% surge year to date, appears to underscore Ark's strategy to optimize its portfolio.
See Also: Ark's NVIDIA Stake Dwindles Further
Other Key Trades:
- Ark Invest purchased 92,853 shares of SomaLogic Inc (NASDAQ:SLGC), a notable player in the biotechnology sector through ARKG.
- The firm also acquired 45,1942 shares of Recursion Pharmaceuticals (NASDAQ:RXRX), marking a significant addition to its holdings through ARKG.
- 22,220 shares of Beam Therapeutics Inc (NASDAQ:BEAM) were added to Ark's portfolio, emphasizing its focus on innovative biotech firms through.
Photo courtesy Benzinga YouTube and Unsplash
Read Next: Is Cathie Wood The Next Warren Buffett?
Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.